Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
0.309
-0.018 (-5.40%)
At close: Dec 5, 2025, 4:00 PM EST
0.319
+0.010 (3.31%)
After-hours: Dec 5, 2025, 6:32 PM EST
Adial Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 7 | 7 | 2 | 6 | 57 | 24 | |
| Market Cap Growth | 14.42% | 188.66% | -60.76% | -89.79% | 131.14% | -1.60% | |
| Enterprise Value | 3 | 1 | 2 | 0 | 50 | 17 | |
| Last Close Price | 0.31 | 1.01 | 1.86 | 5.38 | 67.50 | 42.50 | |
| PB Ratio | 1.63 | 1.61 | 0.56 | 1.76 | 16.12 | 6.14 | |
| P/TBV Ratio | 1.64 | 1.61 | 0.56 | 1.77 | 20.21 | 6.15 | |
| Debt / Equity Ratio | - | - | - | - | 0.07 | - | |
| Quick Ratio | 3.99 | 3.84 | 4.33 | 2.24 | 2.23 | 2.92 | |
| Current Ratio | 4.34 | 4.16 | 4.90 | 2.67 | 2.37 | 3.41 | |
| Return on Equity (ROE) | -155.01% | -323.80% | -190.27% | -318.27% | -518.38% | -195.80% | |
| Return on Assets (ROA) | -79.36% | -105.88% | -82.24% | -102.77% | -170.58% | -103.71% | |
| Return on Capital (ROIC) | -94.51% | -127.04% | -116.98% | -192.78% | -285.36% | -122.77% | |
| Return on Capital Employed (ROCE) | -174.40% | -203.60% | -168.70% | -275.50% | -372.30% | -274.20% | |
| Earnings Yield | -108.77% | -201.82% | -226.15% | -220.51% | -34.34% | -44.52% | |
| FCF Yield | -89.45% | -105.86% | -300.46% | -193.74% | -21.24% | -31.20% | |
| Buyback Yield / Dilution | -199.69% | -240.54% | -42.25% | -34.69% | -49.15% | -26.50% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.